NO981353L - Regulerte gener og anvendelser derav - Google Patents

Regulerte gener og anvendelser derav

Info

Publication number
NO981353L
NO981353L NO981353A NO981353A NO981353L NO 981353 L NO981353 L NO 981353L NO 981353 A NO981353 A NO 981353A NO 981353 A NO981353 A NO 981353A NO 981353 L NO981353 L NO 981353L
Authority
NO
Norway
Prior art keywords
regulated genes
protein
therapy
mitogenic activity
purposes
Prior art date
Application number
NO981353A
Other languages
English (en)
Other versions
NO981353D0 (no
Inventor
Salvatore Oliviero
Original Assignee
Univ Siena
Salvatore Oliviero
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26307843&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO981353(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9519928.7A external-priority patent/GB9519928D0/en
Priority claimed from GBGB9612368.2A external-priority patent/GB9612368D0/en
Application filed by Univ Siena, Salvatore Oliviero filed Critical Univ Siena
Publication of NO981353D0 publication Critical patent/NO981353D0/no
Publication of NO981353L publication Critical patent/NO981353L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Saccharide Compounds (AREA)

Abstract

Nukleotidmolekyl kodende for et protein som blir kodet av et Fos-regulert gen eller et fragment derav, hvori nevnte protein eller fragment derav blir kodet av hvilken som helst av nukleotidsekvensene vist i Figur l eller 2 eller et fragment derav, inkludert alleliske varianter og artsvarianter av nukleotidsekvensene.
NO981353A 1995-09-29 1998-03-25 Regulerte gener og anvendelser derav NO981353L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9519928.7A GB9519928D0 (en) 1995-09-29 1995-09-29 Regulated genes and uses thereof
GBGB9612368.2A GB9612368D0 (en) 1996-06-13 1996-06-13 Regulated genes and uses thereof
PCT/IB1996/001113 WO1997012972A2 (en) 1995-09-29 1996-09-30 Regulated genes and uses thereof

Publications (2)

Publication Number Publication Date
NO981353D0 NO981353D0 (no) 1998-03-25
NO981353L true NO981353L (no) 1998-03-25

Family

ID=26307843

Family Applications (1)

Application Number Title Priority Date Filing Date
NO981353A NO981353L (no) 1995-09-29 1998-03-25 Regulerte gener og anvendelser derav

Country Status (11)

Country Link
US (1) US8383788B2 (no)
EP (2) EP0853668B2 (no)
JP (1) JP4086315B2 (no)
AT (2) ATE459715T1 (no)
AU (1) AU7142996A (no)
CA (1) CA2230957A1 (no)
DE (2) DE69634412T3 (no)
ES (2) ES2341864T3 (no)
IL (1) IL123649A0 (no)
NO (1) NO981353L (no)
WO (1) WO1997012972A2 (no)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6824777B1 (en) 1992-10-09 2004-11-30 Licentia Ltd. Flt4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapy
US7423125B2 (en) 1995-08-01 2008-09-09 Vegenics Limited Antibodies to VEGF-C
PT848755E (pt) 1995-09-08 2003-12-31 Genentech Inc Proteina relacionada com o vegf
DE69634412T3 (de) 1995-09-29 2013-07-04 Vegenics Pty Ltd Regulierte gene und ihre verwendungen
US6828426B1 (en) 1996-07-15 2004-12-07 Chugai Seiyaku Kabushiki Kaisha VEGF-like factor
DK0956339T3 (da) 1996-08-23 2006-01-30 Licentia Oy Rekombinant vaskulær endotelcellevækstfaktor D (VEGF-D)
WO1998024811A2 (en) * 1996-12-06 1998-06-11 Zymogenetics, Inc. Vascular endothelial growth factor
US7125714B2 (en) 1997-02-05 2006-10-24 Licentia Ltd. Progenitor cell materials and methods
US20020137890A1 (en) * 1997-03-31 2002-09-26 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
JP2003517265A (ja) * 1997-12-24 2003-05-27 ルードヴィッヒ インスティテュート フォー キャンサー リサーチ 血管内皮増殖因子ｄを発現する発現ベクターおよび細胞系、およびメラノーマを治療する方法
DE19847422C1 (de) * 1998-10-14 2000-01-13 Forschungszentrum Juelich Gmbh Chinese-Hamster-Ovary-Zellen zur Produktion von Proteinen
JP4739526B2 (ja) 1998-12-07 2011-08-03 ザイモジェネティクス， インコーポレイテッド 成長因子相同体ｚｖｅｇｆ３
WO2001012669A1 (en) * 1999-08-16 2001-02-22 Universita' Degli Studi Di Siena Vegf-d and angiogenic use thereof
JP4981229B2 (ja) 2000-02-25 2012-07-18 ルードヴィッヒ インスティテュート フォー キャンサー リサーチ ハイブリッド血管内皮成長因子ＤＮＡｓおよびタンパク質に関与する物質および方法
US7611711B2 (en) 2001-01-17 2009-11-03 Vegenics Limited VEGFR-3 inhibitor materials and methods
AU2002248372B8 (en) 2001-01-19 2008-03-20 Vegenics Limited FLT4(VEGFR-3) as a target for tumor imaging and anti-tumor therapy
JP2005500045A (ja) * 2001-07-12 2005-01-06 ルードビッヒ、インスティテュート、フォー、キャンサー、リサーチ リンパ管内皮細胞材料および方法
US20040214766A1 (en) * 2001-10-01 2004-10-28 Kari Alitalo VEGF-C or VEGF-D materials and methods for treatment of neuropathologies
US20030113324A1 (en) * 2001-10-01 2003-06-19 Kari Alitalo Neuropilin/VEGF-C/VEGFR-3 materials and methods
WO2004070018A2 (en) * 2003-02-04 2004-08-19 Ludwig Institute For Cancer Research Vegf-b and pdgf modulation of stem cells
EP1635860A2 (en) * 2003-06-12 2006-03-22 Ludwig Institute For Cancer Research Use of vegf-c or vegf-d in reconstructive surgery
WO2005016963A2 (en) * 2003-06-12 2005-02-24 Ludwig Institute For Cancer Research Heparin binding veger-3 ligands
WO2005087177A2 (en) 2004-03-05 2005-09-22 Ludwig Institute For Cancer Research Chimeric anti-vegf-d antibodies and humanized anti-vegf-d antibodies and methods of using same
ITRM20050367A1 (it) * 2005-07-08 2007-01-09 Univ Siena Uso del vegf-d o di suoi frammenti funzionalmente attivi per la ricostruzione o per la riparazione ossea.
ES2363758T3 (es) 2005-08-15 2011-08-16 Vegenics Pty Ltd Vegf y pdgf modificados con propiedades angiogénicas mejoradas.
EP2125895B1 (en) 2007-02-02 2015-04-08 Vegenics Pty Ltd Vegf receptor antagonists for treating organ transplant alloimmunity and arteriosclerosis
US8571840B2 (en) * 2007-03-28 2013-10-29 Autodesk, Inc. Constraint reduction for dynamic simulation
WO2011154308A1 (en) 2010-06-08 2011-12-15 Proyecto De Biomedicina Cima, S.L. New compositions and cell therapy methods for the treatment of cirrhosis
JP6272781B2 (ja) 2012-01-06 2018-01-31 エンボライン， インコーポレイテッド 統合された塞栓保護デバイス
CA2901226C (en) 2013-02-18 2020-11-17 Vegenics Pty Limited Vascular endothelial growth factor binding proteins
JP2019502674A (ja) * 2015-08-25 2019-01-31 ヒスタイド アクツィエンゲゼルシャフト 組織形成誘導用化合物及びその使用
AU2016311298A1 (en) 2015-08-25 2018-02-08 Histide Ag Compounds for inducing tissue formation and uses thereof
US11304792B2 (en) 2019-02-13 2022-04-19 Emboline, Inc. Catheter with integrated embolic protection device

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK135983D0 (da) 1983-03-25 1983-03-25 Novo Industri As Maltogen amylaseenzymprodukt og fremgangsmade til dets fremstilling og anvendelse
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US5968778A (en) * 1989-01-12 1999-10-19 Jurgen Hoppe PDGF-AB, preparation process and pharmaceuticals containing them
US5194596A (en) * 1989-07-27 1993-03-16 California Biotechnology Inc. Production of vascular endothelial cell growth factor
JP3024311B2 (ja) 1991-10-03 2000-03-21 味の素株式会社 Ｉｌ−２受容体重鎖に結合するポリペプチド
JPH05271294A (ja) 1992-01-24 1993-10-19 Japan Found Cancer Res ヒトプロヒビチンおよびそれをコードするｄｎａ
WO1994002511A1 (en) 1992-07-27 1994-02-03 Pfizer Inc. Calcium channel blocking polypeptide from agelenopsis aperta
ES2249762T3 (es) * 1994-03-08 2006-04-01 Human Genome Sciences, Inc. Factor de crecimiento del endotelio vascular 2.
US5814464A (en) 1994-10-07 1998-09-29 Regeneron Pharma Nucleic acids encoding TIE-2 ligand-2
US6645933B1 (en) 1995-08-01 2003-11-11 Helsinki University Licensing Ltd. Oy Receptor ligand VEGF-C
US6221839B1 (en) * 1994-11-14 2001-04-24 Helsinki University Licensing Ltd. Oy FIt4 ligand and methods of use
JPH08185216A (ja) 1994-12-28 1996-07-16 Meidensha Corp 工具姿勢パラメータ設定方法及びロボット制御装置
US5928939A (en) 1995-03-01 1999-07-27 Ludwig Institute For Cancer Research Vascular endothelial growth factor-b and dna coding therefor
HU223438B1 (hu) 1995-03-02 2004-07-28 Amrad Operations Pty. Ltd. Új növekedési faktor és ezt kódoló génszekvencia
WO1996039421A1 (en) 1995-06-06 1996-12-12 Human Genome Sciences, Inc. Human vascular endothelial growth factor 3
DE69634412T3 (de) 1995-09-29 2013-07-04 Vegenics Pty Ltd Regulierte gene und ihre verwendungen
US6828426B1 (en) * 1996-07-15 2004-12-07 Chugai Seiyaku Kabushiki Kaisha VEGF-like factor
DK0956339T3 (da) * 1996-08-23 2006-01-30 Licentia Oy Rekombinant vaskulær endotelcellevækstfaktor D (VEGF-D)
WO1998024811A2 (en) 1996-12-06 1998-06-11 Zymogenetics, Inc. Vascular endothelial growth factor
JP2001500385A (ja) 1997-02-18 2001-01-16 ルードヴィッヒ・インスティテュート・フォア・キャンサー・リサーチ 組換え血管内皮増殖因子ｂ（ｖｅｇｆ−ｂ）ｄｎａによるトランスジェニック動物およびその利用方法
PT1140175E (pt) * 1998-12-21 2006-06-30 Ludwig Inst Cancer Res Anticorpos para o vegf-d truncado e suas utilizacoes
WO2001012669A1 (en) * 1999-08-16 2001-02-22 Universita' Degli Studi Di Siena Vegf-d and angiogenic use thereof
PL2247603T3 (pl) 2008-02-12 2017-04-28 Dow Agrosciences Llc Kompozycje szkodnikobójcze

Also Published As

Publication number Publication date
ES2239338T3 (es) 2005-09-16
IL123649A0 (en) 1998-10-30
JP2001501442A (ja) 2001-02-06
EP0853668B2 (en) 2013-03-06
NO981353D0 (no) 1998-03-25
EP0853668B1 (en) 2005-03-02
CA2230957A1 (en) 1997-04-10
WO1997012972A3 (en) 1997-06-12
EP1553182A3 (en) 2008-03-05
US20020123481A1 (en) 2002-09-05
ATE290077T1 (de) 2005-03-15
US8383788B2 (en) 2013-02-26
WO1997012972A2 (en) 1997-04-10
DE69638142D1 (de) 2010-04-15
JP4086315B2 (ja) 2008-05-14
EP1553182B1 (en) 2010-03-03
ATE459715T1 (de) 2010-03-15
ES2341864T3 (es) 2010-06-29
EP0853668A2 (en) 1998-07-22
DE69634412D1 (de) 2005-04-07
DE69634412T3 (de) 2013-07-04
EP1553182A2 (en) 2005-07-13
ES2239338T5 (es) 2013-05-31
DE69634412T2 (de) 2005-12-15
AU7142996A (en) 1997-04-28

Similar Documents

Publication Publication Date Title
NO981353L (no) Regulerte gener og anvendelser derav
WO1999033982A3 (en) Human genes and gene expression products i
IL118201A0 (en) Erythropoietin free of animal proteins processes for production and use thereof
EP1398326A3 (en) Monoclonal antibodies against recombinant stratum corneum chymotryptic enzyme (SCCE)
GB9715660D0 (en) Proteins
WO1999038972A9 (en) Human genes and gene expression products ii
WO1999058675A3 (en) Human genes and gene expression products v
ATE273388T1 (de) Veränderte menschliche c3-proteine
NO992916L (no) Fosfodiesterase 8A
NO910982L (no) Uratoksydase-aktivt protein, rekombinant gen som koder for det, ekspresjonsvektor, mikroorganismer og transformerteceller.
DK0941252T3 (da) Enkeltkædede anti-P53-antistoffragmenter og anvendelse heraf
ATE309371T1 (de) Protein mit dnase-aktivität
WO2000018916A3 (en) Human genes and gene expression products
DE50015355D1 (de) Mit trp-proteinen verwandtes protein mtr1 und dieses codierende dna-sequenz
DK0870015T3 (da) Xylanaser, gener, der koder for disse, samt anvendelser deraf
NO981707L (no) Xylanase, oligonukleotidsekvens som koder for xylanase og anvendelse derav
ATE307201T1 (de) Srcr domäne-enthaltendes protein
WO2002088345A3 (en) Murine dnasex, medicament containing the same and non-human mammal comprising modified dnasex gene
ATE234929T1 (de) Vektor zur expression von therapeutisch relevanten genen
MX9709596A (es) Adn catal ??tico.
NO920500D0 (no) Nukleotidsekvens som koder for et ytre membranprotein franeisseria meningitidis, samt anvendelse derav